Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q2 2016 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2016-08-11

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 11, 2016

Total Value: $97.54M (88.5% shares, 11.5% debt)

Holdings (23)

— SCICLONE PHARMACEUTICALS INC 14.5%

Value $14.14M Shares 1,082,532 Share Price $13.06 Est. Cost/Share $9.97 Unrealized @ Report Date —

— Viveve Medical, Inc 10.9%

Value $10.66M Shares 2,599,711 Share Price $4.10 Est. Cost/Share $4.10 Unrealized @ Report Date —

— Aegerion Pharmaceuticals, Inc. (NOTES) 10.1%

Value $9.861M Shares 17,300,000 Share Price $0.57 Est. Cost/Share $0.57 Unrealized @ Report Date —

VNDA VANDA PHARMACEUTICALS INC 9.3%

Value $9.081M Shares 811,563 Share Price $11.19 * Est. Cost/Share $9.85 Unrealized @ Report Date -1.7%

— TOBIRA THERAPEUTICS INC 8.2%

Value $8.008M Shares 637,567 Share Price $12.56 Est. Cost/Share $10.05 Unrealized @ Report Date —

— PAIN THERAPEUTICS INC 6.4%

Value $6.215M Shares 2,837,878 Share Price $2.19 Est. Cost/Share $1.75 Unrealized @ Report Date —

— QLT Inc. 5.5%

Value $5.367M Shares 3,779,274 Share Price $1.42 Est. Cost/Share $1.42 Unrealized @ Report Date —

— SAGENT PHARMACEUTICALS INC 5.5%

Value $5.337M Shares 356,307 Share Price $14.98 Est. Cost/Share $15.85 Unrealized @ Report Date —

VCEL VERICEL CORP 5.2%

Value $5.063M Shares 2,250,000 Share Price $2.25 * Est. Cost/Share $2.48 Unrealized @ Report Date +16.0%

— CUTERA INC 5.0%

Value $4.91M Shares 438,000 Share Price $11.21 Est. Cost/Share $11.59 Unrealized @ Report Date —

— RECRO PHARMA INC 3.5%

Value $3.408M Shares 428,670 Share Price $7.95 Est. Cost/Share $7.68 Unrealized @ Report Date —

— Alere Inc. 3.2%

Value $3.126M Shares 75,000 Share Price $41.68 Est. Cost/Share $41.68 Unrealized @ Report Date —

— Sucampo Pharmaceuticals, Inc. 2.4%

Value $2.346M Shares 213,860 Share Price $10.97 Est. Cost/Share $10.97 Unrealized @ Report Date —

PCRX Pacira Pharmaceuticals, Inc. 1.8%

Value $1.759M Shares 52,157 Share Price $33.73 * Est. Cost/Share $49.15 Unrealized @ Report Date 0.0%

— PERNIX THERAPEUTICS HOLDINGS 1.4%

Value $1.38M Shares 6,000,000 Share Price $0.23 Est. Cost/Share $0.23 Unrealized @ Report Date —

— Flamel Technologies SA 1.4%

Value $1.375M Shares 128,005 Share Price $10.74 Est. Cost/Share $10.74 Unrealized @ Report Date —

— BioSpecifics Technologies Corp. 1.2%

Value $1.198M Shares 30,000 Share Price $39.93 Est. Cost/Share $35.57 Unrealized @ Report Date —

— Enanta Pharmaceuticals, Inc. 1.2%

Value $1.16M Shares 52,616 Share Price $22.05 Est. Cost/Share $22.05 Unrealized @ Report Date —

— DERMA SCIENCES INC 1.1%

Value $1.116M Shares 283,306 Share Price $3.94 Est. Cost/Share $4.57 Unrealized @ Report Date —

VCYT Veracyte, Inc. 1.0%

Value $940K Shares 186,926 Share Price $5.03 * Est. Cost/Share $5.36 Unrealized @ Report Date 0.0%

CPIX Cumberland Pharmaceuticals, Inc. 0.6%

Value $580K Shares 128,798 Share Price $4.50 Est. Cost/Share $4.58 Unrealized @ Report Date 0.0%

— Aviragen Therapeutics, Inc. 0.4%

Value $412K Shares 294,269 Share Price $1.40 Est. Cost/Share $1.40 Unrealized @ Report Date —

— DURECT Corporation 0.1%

Value $98,000 Shares 80,160 Share Price $1.22 Est. Cost/Share $1.22 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	SCICLONE PHARMACEUTICALS INC	1,082,532	$14.14M	14.5%	$13.06	$9.97	—	COM	80862K104
—	Viveve Medical, Inc	2,599,711	$10.66M	10.9%	$4.10	$4.10	—	COM	092852W20
—	Aegerion Pharmaceuticals, Inc. (NOTES)	17,300,000	$9.861M	10.1%	$0.57	$0.57	—	NOTE	00767EAB8
VNDA	VANDA PHARMACEUTICALS INC	811,563	$9.081M	9.3%	$11.19 *	$9.85	-1.7%	COM	921659108
—	TOBIRA THERAPEUTICS INC	637,567	$8.008M	8.2%	$12.56	$10.05	—	COM	88883P101
—	PAIN THERAPEUTICS INC	2,837,878	$6.215M	6.4%	$2.19	$1.75	—	COM	69562K100
—	QLT Inc.	3,779,274	$5.367M	5.5%	$1.42	$1.42	—	COM	746927102
—	SAGENT PHARMACEUTICALS INC	356,307	$5.337M	5.5%	$14.98	$15.85	—	COM	786692103
VCEL	VERICEL CORP	2,250,000	$5.063M	5.2%	$2.25 *	$2.48	+16.0%	COM	92346J108
—	CUTERA INC	438,000	$4.91M	5.0%	$11.21	$11.59	—	COM	232109108
—	RECRO PHARMA INC	428,670	$3.408M	3.5%	$7.95	$7.68	—	COM	75629F109
—	Alere Inc.	75,000	$3.126M	3.2%	$41.68	$41.68	—	COM	01449J105
—	Sucampo Pharmaceuticals, Inc.	213,860	$2.346M	2.4%	$10.97	$10.97	—	COM	864909106
PCRX	Pacira Pharmaceuticals, Inc.	52,157	$1.759M	1.8%	$33.73 *	$49.15	0.0%	COM	695127100
—	PERNIX THERAPEUTICS HOLDINGS	6,000,000	$1.38M	1.4%	$0.23	$0.23	—	NOTE	71426VAK4
—	Flamel Technologies SA	128,005	$1.375M	1.4%	$10.74	$10.74	—	COM	338488109
—	BioSpecifics Technologies Corp.	30,000	$1.198M	1.2%	$39.93	$35.57	—	COM	090931106
—	Enanta Pharmaceuticals, Inc.	52,616	$1.16M	1.2%	$22.05	$22.05	—	COM	029251M10
—	DERMA SCIENCES INC	283,306	$1.116M	1.1%	$3.94	$4.57	—	COM	249827502
VCYT	Veracyte, Inc.	186,926	$940K	1.0%	$5.03 *	$5.36	0.0%	COM	92337F107
CPIX	Cumberland Pharmaceuticals, Inc.	128,798	$580K	0.6%	$4.50	$4.58	0.0%	COM	230770109
—	Aviragen Therapeutics, Inc.	294,269	$412K	0.4%	$1.40	$1.40	—	COM	053761102
—	DURECT Corporation	80,160	$98,000	0.1%	$1.22	$1.22	—	COM	266605104